ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 71 filers reported holding ATHIRA PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,718 | -37.7% | 107,781 | -9.0% | 0.00% | – |
| Q2 2023 | $349,519 | -82.1% | 118,481 | -84.9% | 0.00% | – |
| Q1 2023 | $1,956,525 | -60.4% | 782,610 | -49.8% | 0.00% | – |
| Q4 2022 | $4,938,942 | +112.6% | 1,558,026 | +99.2% | 0.00% | – |
| Q3 2022 | $2,323,000 | -16.3% | 782,154 | -14.1% | 0.00% | – |
| Q2 2022 | $2,777,000 | -75.1% | 910,375 | +10.0% | 0.00% | -100.0% |
| Q1 2022 | $11,172,000 | +44.0% | 827,574 | +39.0% | 0.00% | – |
| Q4 2021 | $7,757,000 | +70.4% | 595,294 | +22.7% | 0.00% | – |
| Q3 2021 | $4,552,000 | +2.6% | 485,253 | +12.0% | 0.00% | – |
| Q2 2021 | $4,437,000 | +13.6% | 433,318 | +104.1% | 0.00% | – |
| Q1 2021 | $3,907,000 | -42.0% | 212,351 | +7.9% | 0.00% | – |
| Q4 2020 | $6,742,000 | – | 196,855 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 714,763 | $2,265,799 | 2.16% |
| Perceptive Advisors | 4,797,278 | $15,207,371 | 0.43% |
| Potomac Capital Management, Inc. | 80,000 | $254 | 0.30% |
| Bristlecone Advisors, LLC | 696,629 | $2,208,314 | 0.27% |
| TANG CAPITAL MANAGEMENT LLC | 485,234 | $1,538,192 | 0.22% |
| RA Capital Management | 1,881,300 | $5,963,721 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 270,989 | $859 | 0.11% |
| PATHSTONE FAMILY OFFICE, LLC | 3,631,080 | $8,182,650 | 0.07% |
| Laird Norton Wetherby Trust Company, LLC | 130,000 | $412,100 | 0.06% |
| Forefront Analytics, LLC | 22,350 | $70,851 | 0.04% |